Ankerst DP - Search Results

1

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

Moinpour CM, Darke AK, Donaldson GW, Thompson IM Jr, Langley C, Ankerst DP, Patrick DL, Ware JE Jr, Ganz PA, Shumaker SA, Lippman SM, Coltman CA Jr. Moinpour CM, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2007 Jul 4;99(13):1025-35. doi: 10.1093/jnci/djm023. Epub 2007 Jun 27. J Natl Cancer Inst. 2007. PMID: 17596576 Clinical Trial.

2

Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.

Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM. Etzioni RD, et al. Among authors: ankerst dp. J Urol. 2005 Sep;174(3):877-81. doi: 10.1097/01.ju.0000169255.64518.fb. J Urol. 2005. PMID: 16093979 Clinical Trial.

3

Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.

Etzioni RD, Ankerst DP, Weiss NS, Inoue LY, Thompson IM. Etzioni RD, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2007 Oct 17;99(20):1510-5. doi: 10.1093/jnci/djm171. Epub 2007 Oct 9. J Natl Cancer Inst. 2007. PMID: 17925534

4

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr. Thompson IM, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131. J Natl Cancer Inst. 2006. PMID: 16622122

5

Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr. Thompson IM, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2006 Aug 16;98(16):1128-33. doi: 10.1093/jnci/djj307. J Natl Cancer Inst. 2006. PMID: 16912265 Clinical Trial.

6

New answers from the Prostate Cancer Prevention Trial on the chemoprevention of prostate cancer.

Ankerst DP, Thompson IM. Ankerst DP, et al. Arch Ital Urol Androl. 2006 Dec;78(4):154-6. Arch Ital Urol Androl. 2006. PMID: 17269622

7

Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies.

Parekh DJ, Ankerst DP, Thompson IM. Parekh DJ, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2007 Apr 4;99(7):496-7. doi: 10.1093/jnci/djk129. J Natl Cancer Inst. 2007. PMID: 17405989 No abstract available.

8

Screening for prostate cancer.

Brawley OW, Ankerst DP, Thompson IM. Brawley OW, et al. Among authors: ankerst dp. CA Cancer J Clin. 2009 Jul-Aug;59(4):264-73. doi: 10.3322/caac.20026. Epub 2009 Jun 29. CA Cancer J Clin. 2009. PMID: 19564245 Free article.

9

Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma.

Thompson IM, Ankerst DP, Tangen CM. Thompson IM, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2010 Sep 8;102(17):1299-301. doi: 10.1093/jnci/djq313. Epub 2010 Aug 19. J Natl Cancer Inst. 2010. PMID: 20724727 Free PMC article. No abstract available.

10

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome.

Vickers AJ, Sjoberg DD, Ankerst DP, Tangen CM, Goodman PJ, Thompson IM Jr. Vickers AJ, et al. Among authors: ankerst dp. Cancer. 2013 Aug 15;119(16):3007-11. doi: 10.1002/cncr.28114. Epub 2013 May 29. Cancer. 2013. PMID: 23720006 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters